Literature DB >> 15885895

Bioactivation of 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone: evidence for DNA adduct formation mediated by cytochrome P450 enzymes and peroxidases.

Volker M Arlt1, Colin J Henderson, C Roland Wolf, Heinz H Schmeiser, David H Phillips, Marie Stiborova.   

Abstract

3-Nitrobenzanthrone (3-NBA) is a suspected human carcinogen found in diesel exhaust and ambient air pollution. The main metabolite of 3-NBA, 3-aminobenzanthrone (3-ABA), was detected in the urine of salt mining workers occupationally exposed to diesel emissions. We evaluated the role of hepatic cytochrome P450 (CYP) enzymes in the activation of 3-ABA in vivo by treating hepatic cytochrome P450 oxidoreductase (POR)-null mice and wild-type littermates intraperitoneally with 0.2 and 2mg/kg body weight of 3-ABA. Hepatic POR-null mice lack POR-mediated CYP enzyme activity in the liver. Using the (32)P-postlabelling method, multiple 3-ABA-derived DNA adducts were observed in liver DNA from wild-type mice, qualitatively similar to those formed in incubations using human hepatic microsomes. The adduct pattern was also similar to those formed by the nitroaromatic counterpart 3-NBA and which derive from reductive metabolites of 3-NBA bound to purine bases in DNA. DNA binding by 3-ABA in the livers of the null mice was undetectable at the lower dose and substantially reduced (by up to 80%), relative to wild-type mice, at the higher dose. These data indicate that POR-mediated CYP enzyme activities are important for the oxidative activation of 3-ABA in livers, confirming recent results indicating that CYP1A1 and -1A2 are mainly responsible for the metabolic activation of 3-ABA in human hepatic microsomes. No difference in DNA binding was found in kidney and bladder between null and wild-type mice, suggesting that cells in these extrahepatic organs have the metabolic capacity to oxidize 3-ABA to species forming the same 3-ABA-derived DNA adducts, independently from the CYP-mediated oxidation in the liver. We determined that different model peroxidases are able to catalyse DNA adduct formation by 3-ABA in vitro. Horseradish peroxidase (HRP), lactoperoxidase (LPO), myeloperoxidase (MPO), and prostaglandin H synthase (PHS) were all effective in activating 3-ABA in vitro, forming DNA adducts qualitatively similar to those formed in vivo in mice treated with 3-ABA and to those found in DNA reacted with N-hydroxy-3-aminobenzanthrone (N-OH-ABA). Collectively, these results suggest that both CYPs and peroxidases may play an important role in metabolizing 3-ABA to reactive DNA adduct forming species.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15885895     DOI: 10.1016/j.canlet.2005.03.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.

Authors:  Jessica R Murray; Clementina A Mesaros; Volker M Arlt; Albrecht Seidel; Ian A Blair; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2018-11-08       Impact factor: 3.739

3.  Investigation of mechanism(s) of DNA damage induced by 4-monochlorobiphenyl (PCB3) metabolites.

Authors:  Wei Xie; Kai Wang; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Int       Date:  2010-02-04       Impact factor: 9.621

4.  Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling.

Authors:  Marie Stiborova
Journal:  J Vis Exp       Date:  2018-03-20       Impact factor: 1.355

5.  Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.

Authors:  Volker M Arlt; Miriam C Poirier; Sarah E Sykes; Kaarthik John; Michaela Moserova; Marie Stiborova; C Roland Wolf; Colin J Henderson; David H Phillips
Journal:  Toxicol Lett       Date:  2012-07-01       Impact factor: 4.372

6.  Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.

Authors:  Dagmar Aimová; Jitka Poljaková; Věra Kotrbová; Michaela Moserová; Eva Frei; Volker M Arlt; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2008-09

7.  Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers.

Authors:  Marie Stiborová; Jiří Hudeček; Eva Frei; Heinz H Schmeiser
Journal:  Interdiscip Toxicol       Date:  2008-06

8.  Rat cytochromes P450 oxidize 3-aminobenzanthrone, a human metabolite of the carcinogenic environmental pollutant 3-nitrobenzanthrone.

Authors:  Jana Mizerovská; Helena Dračínská; Volker M Arlt; Jiří Hudeček; Petr Hodek; Heinz H Schmeiser; Eva Frei; Marie Stiborová
Journal:  Interdiscip Toxicol       Date:  2008-09

9.  Incorporation of 3-aminobenzanthrone into 2'-deoxyoligonucleotides and its impact on duplex stability.

Authors:  Mark Lukin; Tanya Zaliznyak; Francis Johnson; Carlos R de Los Santos
Journal:  J Nucleic Acids       Date:  2011-11-17

Review 10.  The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN™) mice and pure enzymes.

Authors:  Marie Stiborová; Věra Černá; Michaela Moserová; Iveta Mrízová; Volker M Arlt; Eva Frei
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.